Results 261 to 270 of about 924,359 (286)

SARS-CoV-2 pathogenesis

Nature Reviews Microbiology, 2022
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating pandemic. Although most people infected with SARS-CoV-2 develop a mild to moderate disease with virus replication restricted mainly to the upper airways, some progress to having a life-threatening pneumonia.
Mart M Lamers, Bart L Haagmans
exaly   +3 more sources

SARS-CoV-2

2022
The basic proteinase of SARS-CoV-2 M^pro virus (3CLpro) controls a number of activities of the replication complex of the virus and is therefore a target for the development of specific inhibitors. In the development of drugs against SARS-CoV-2, much attention is paid to previously known effective compounds.
  +5 more sources

Airborne SARS-CoV-2

BMJ, 2022
openaire   +2 more sources

SARS-CoV-2 variants, spike mutations and immune escape

Nature Reviews Microbiology, 2021
William T Harvey, Alessandro Maria Carabelli, Benjamin C Jackson   +2 more
exaly  

The evolution of SARS-CoV-2

Nature Reviews Microbiology, 2023
, Martin Beer, Nikolaos I Stilianakis
exaly  

Mechanisms of SARS-CoV-2 entry into cells

Nature Reviews Molecular Cell Biology, 2021
Cody B Jackson, Michael Farzan, Bing Chen   +2 more
exaly  

Cardio‐oncology care in the era of the coronavirus disease 2019 (COVID‐19) pandemic: An International Cardio‐Oncology Society (ICOS) statement

Ca-A Cancer Journal for Clinicians, 2020
Daniel J Lenihan, Joseph Carver, Charles Porter   +2 more
exaly  

Structural biology of SARS-CoV-2 and implications for therapeutic development

Nature Reviews Microbiology, 2021
Haitao Yang, Zihe Rao
exaly  

Characteristics of SARS-CoV-2 and COVID-19

Nature Reviews Microbiology, 2020
Ben Hu, Hua Guo, Peng Zhou
exaly  

SARS-CoV-2 variant biology: immune escape, transmission and fitness

Nature Reviews Microbiology, 2023
Alessandro Maria Carabelli, William T Harvey, Joseph Hughes   +2 more
exaly